1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mammalian Cell Banking Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Master Cell Banks
1.2.3 Working Cell Banks
1.2.4 End of Production Cell Banks
1.2.5 Research & Development Cell Banks
1.2.6 Others
1.3 Market by Application
1.3.1 Global Mammalian Cell Banking Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Academic & Research Laboratories
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Research Organizations (CROs)
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mammalian Cell Banking Market Perspective (2017-2028)
2.2 Mammalian Cell Banking Growth Trends by Region
2.2.1 Mammalian Cell Banking Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Mammalian Cell Banking Historic Market Size by Region (2017-2022)
2.2.3 Mammalian Cell Banking Forecasted Market Size by Region (2023-2028)
2.3 Mammalian Cell Banking Market Dynamics
2.3.1 Mammalian Cell Banking Industry Trends
2.3.2 Mammalian Cell Banking Market Drivers
2.3.3 Mammalian Cell Banking Market Challenges
2.3.4 Mammalian Cell Banking Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mammalian Cell Banking Players by Revenue
3.1.1 Global Top Mammalian Cell Banking Players by Revenue (2017-2022)
3.1.2 Global Mammalian Cell Banking Revenue Market Share by Players (2017-2022)
3.2 Global Mammalian Cell Banking Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Mammalian Cell Banking Revenue
3.4 Global Mammalian Cell Banking Market Concentration Ratio
3.4.1 Global Mammalian Cell Banking Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mammalian Cell Banking Revenue in 2021
3.5 Mammalian Cell Banking Key Players Head office and Area Served
3.6 Key Players Mammalian Cell Banking Product Solution and Service
3.7 Date of Enter into Mammalian Cell Banking Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mammalian Cell Banking Breakdown Data by Type
4.1 Global Mammalian Cell Banking Historic Market Size by Type (2017-2022)
4.2 Global Mammalian Cell Banking Forecasted Market Size by Type (2023-2028)
5 Mammalian Cell Banking Breakdown Data by Application
5.1 Global Mammalian Cell Banking Historic Market Size by Application (2017-2022)
5.2 Global Mammalian Cell Banking Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Mammalian Cell Banking Market Size (2017-2028)
6.2 North America Mammalian Cell Banking Market Size by Country (2017-2022)
6.3 North America Mammalian Cell Banking Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Mammalian Cell Banking Market Size (2017-2028)
7.2 Europe Mammalian Cell Banking Market Size by Country (2017-2022)
7.3 Europe Mammalian Cell Banking Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Mammalian Cell Banking Market Size (2017-2028)
8.2 Asia-Pacific Mammalian Cell Banking Market Size by Country (2017-2022)
8.3 Asia-Pacific Mammalian Cell Banking Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Mammalian Cell Banking Market Size (2017-2028)
9.2 Latin America Mammalian Cell Banking Market Size by Country (2017-2022)
9.3 Latin America Mammalian Cell Banking Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Mammalian Cell Banking Market Size (2017-2028)
10.2 Middle East & Africa Mammalian Cell Banking Market Size by Country (2017-2022)
10.3 Middle East & Africa Mammalian Cell Banking Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sartorius Stedim BioOutsource Limited.
11.1.1 Sartorius Stedim BioOutsource Limited. Company Detail
11.1.2 Sartorius Stedim BioOutsource Limited. Business Overview
11.1.3 Sartorius Stedim BioOutsource Limited. Mammalian Cell Banking Introduction
11.1.4 Sartorius Stedim BioOutsource Limited. Revenue in Mammalian Cell Banking Business (2017-2022)
11.1.5 Sartorius Stedim BioOutsource Limited. Recent Development
11.2 Charles River Laboratories.
11.2.1 Charles River Laboratories. Company Detail
11.2.2 Charles River Laboratories. Business Overview
11.2.3 Charles River Laboratories. Mammalian Cell Banking Introduction
11.2.4 Charles River Laboratories. Revenue in Mammalian Cell Banking Business (2017-2022)
11.2.5 Charles River Laboratories. Recent Development
11.3 Eurofins DiscoverX Corporation
11.3.1 Eurofins DiscoverX Corporation Company Detail
11.3.2 Eurofins DiscoverX Corporation Business Overview
11.3.3 Eurofins DiscoverX Corporation Mammalian Cell Banking Introduction
11.3.4 Eurofins DiscoverX Corporation Revenue in Mammalian Cell Banking Business (2017-2022)
11.3.5 Eurofins DiscoverX Corporation Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Detail
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Mammalian Cell Banking Introduction
11.4.4 Merck KGaA Revenue in Mammalian Cell Banking Business (2017-2022)
11.4.5 Merck KGaA Recent Development
11.5 Lonza Group Ltd
11.5.1 Lonza Group Ltd Company Detail
11.5.2 Lonza Group Ltd Business Overview
11.5.3 Lonza Group Ltd Mammalian Cell Banking Introduction
11.5.4 Lonza Group Ltd Revenue in Mammalian Cell Banking Business (2017-2022)
11.5.5 Lonza Group Ltd Recent Development
11.6 VIRUSURE
11.6.1 VIRUSURE Company Detail
11.6.2 VIRUSURE Business Overview
11.6.3 VIRUSURE Mammalian Cell Banking Introduction
11.6.4 VIRUSURE Revenue in Mammalian Cell Banking Business (2017-2022)
11.6.5 VIRUSURE Recent Development
11.7 Altogen Labs
11.7.1 Altogen Labs Company Detail
11.7.2 Altogen Labs Business Overview
11.7.3 Altogen Labs Mammalian Cell Banking Introduction
11.7.4 Altogen Labs Revenue in Mammalian Cell Banking Business (2017-2022)
11.7.5 Altogen Labs Recent Development
11.8 Abzena Ltd
11.8.1 Abzena Ltd Company Detail
11.8.2 Abzena Ltd Business Overview
11.8.3 Abzena Ltd Mammalian Cell Banking Introduction
11.8.4 Abzena Ltd Revenue in Mammalian Cell Banking Business (2017-2022)
11.8.5 Abzena Ltd Recent Development
11.9 Northway Biotechpharma
11.9.1 Northway Biotechpharma Company Detail
11.9.2 Northway Biotechpharma Business Overview
11.9.3 Northway Biotechpharma Mammalian Cell Banking Introduction
11.9.4 Northway Biotechpharma Revenue in Mammalian Cell Banking Business (2017-2022)
11.9.5 Northway Biotechpharma Recent Development
11.10 Selexis SA
11.10.1 Selexis SA Company Detail
11.10.2 Selexis SA Business Overview
11.10.3 Selexis SA Mammalian Cell Banking Introduction
11.10.4 Selexis SA Revenue in Mammalian Cell Banking Business (2017-2022)
11.10.5 Selexis SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
